Industry Collaboration

Collaborating with Industry

CIRM wants to foster collaboration with academic researchers and industry. CIRM’s mission is to accelerate the development of stem cell therapies for patients with unmet medical needs. To better serve our mission, CIRM launched ‘CIRM 2.0’, a radical overhaul of the way the Agency does business, implementing efficient new systems and programs that place added emphasis on:

Speed

Partnerships

Patients

CIRM 2.0 makes it easier for both companies and academic researchers with promising projects to partner with CIRM to get the support they need when they need it, reducing the time from application to funding from around two years to just 120 days. You can read the Program Announcements for these opportunities on our Funding Opportunities Page.

At CIRM, we never forget that we were created by the people of California to accelerate stem cell treatments to patients with unmet medical needs, and act with a sense of urgency commensurate with that mission. We are always seeking novel, high quality programs to built and enhance our robust portfolio. With $3 billion in funding and approximately 300 active stem cell programs in our portfolio, CIRM is the world’s largest institution dedicated to helping people by bringing the future of cellular medicine closer to reality.